Pan-European consultation on reforming European Union Novel Foods
regulations should remove the controversial substantial equivalence
clause, according to an Irish Food Safety
Authority (FSAI) representative.
Hawaiian microalgae specialist Cyanotech has received the green
light to sell its astaxanthin in the EU under novel foods
regulations, opening up a new market that it says has great
potential for the antioxidant ingredient.
Chinese ingredients supplier Fenchem is seeking substantial
equivalence for its Cholevel branded phytosterol under European
novel foods legislation, which it expects will be a big spark for
the product line.
Danish company MediMush is seeking to introduce a new shiitake
mushrooms source of beta-glucan for dietary supplements sold in the
EU, and has sought substantial equivalence status under the bloc's
novel foods legislation.
Many overseas companies selling nutraceuticals in Europe are
risking having their products removed from the market as they have
not gone through the correct regulatory channels, warns a
consultant to the natural products industry.
The safety of a new glucosamine ingredient, being produced through
fermentation by Cargill, has been approved by an expert panel in
the UK, a major step towards its use in the European Union,
writes Dominique Patton.
Spanish manufacturer Vitatene moves one step closer towards market
approval for its lycopene food ingredient derived from the fungus
Blakeslea trispora with the UK's novel foods committee
satisfied by safety evidence provided...